The Treatment of Osteoarthritis Lies in Our Own Joints

Everyone succumbs to osteoarthritis as they age. Osteoarthritis causes pain and stiffness in the joints and is the most common form of arthritis. However protection or sparring of our joints from progressive degeneration due to osteoarthritis could be well determined by the endocannabioid system which is found in the synovial tissue and fluid that surround joints. rnWho gets Osteoarthritis A recent study conducted by researchers at the University of Edinburgh is suggesting a strong link between osteoarthritis and the endocannabioid system. The endocannabinoid system is composed of cannabinoid receptors (which are more popularly known for managing the body’s response to the psychoactive effects of cannabis) and endocannabinoid ligands. The type 2 cannabinoid receptor (CB2), is proving to be a significant source of defence against this potentially debilitating disease, which can affect all ages and is particularly common among the elderly. rnThe findings, which offer the eventual promise of new forms of protection, were presented at the 41st European Calcified Tissue Society Congress, held in Prague on May 17 – 20, 2014, by Professor Stuart Ralston, Arthritis Research UK Professor of Rheumatology at the University of Edinburgh. Prof Ralston described how a study of mice with destabilised knee joints showed that cartilage degeneration, which lies at the heart of osteoarthritis, was up to 40% more severe in mice who were deficient in CB2 receptors, when compared to ‘normal’ mice, with the figure reaching up to 60% more severe among aged mice that developed spontaneous osteoarthritis and were deficient in CB2 receptors, when compared to their aged ‘normal’ counterparts. rnThe study also showed that a synthesised cannabinoid ligand, HU308, significantly inhibited the progression of arthritis in younger mice with normal levels of CB2 and had no effect on those with CB2 receptor deficiency. rnWell I know it’s a long way to study the role of the CB2 pathway to develop treatments of osteoarthritis. We are heading in the right direction.rnSource: http://www.medicalnewstoday.comrnDr.Anbarrasu N.D. Uteshiya Medicare Private Limited Uteshiya Medicare is one of the leading prosthesis manufacturer and supplier in India for orthopedic implants approved by ISO 13485:2003 and the FDA. The company was established by Uteshiya Group of Industries in year 2013 in the domain of Orthopedic prosthesis. Its products include interlocking nail, locking plates, bone plates, Bone screws, hip implants and much more. The company is manufacturing and producing outstanding Orthopedic Implants with a strong focus on higher service levels, finest customer based designs and top most technical solutions.For more info Visit www.uteshiyamedicare.com